Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[Graft-versus-host disease associated with lenalidomide maintenance after allogeneic transplantation for relapsed/refractory multiple myeloma]Nobuhiro Tsukada, Sumito Shingaki, Masahiro Ikeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Induction treatment with bortezomib-cyclophosphamide-dexamethasone (CyBorD) for newly diagnosed transplant-eligible patients with multiple myeloma]Nobuhiro Tsukada, Masahiro Ikeda, Sumito Shingaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2014
Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemiaAiri Hamano, Sumito Shingaki, Yu Abe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 7, 2017
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancyMasahiro Ikeda, Rina Oba, Yumiko Yoshiki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[The clinical significance of decrease in CD138 positive cell ratio in multiple myeloma]Junko Inoue, Masahiro Ikeda, Sumito Shingaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 7, 2020
[Elotuzumab treatment for a multiple myeloma patient relapsing after allogenic stem cell transplantation]Kota Sato, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
European Journal of Haematology|November 17, 2019
The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myelomaKiyoshi Okazuka, Tadao Ishida, Junichiro Nashimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2017
[IgE-κ type multiple myeloma achieving complete response with novel agents]Tomomi Takei, Tadao Ishida, Masahiro Ikeda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Clinical characteristics of young multiple myeloma patients: a single-center analysis of 30 patients]Yumiko Yoshiki, Nobuhiro Tsukada, Junichiro Nashimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2020
[Cost-effectiveness of peripheral blood stem cell collection using plerixafor: a single-center study]Mizuki Ogura, Nobuhiro Tsukada, Takao Yogo, et al.
Pageof 3